EP1696900
USE OF TREPROSTINIL TO TREAT ISCHEMIC LESIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.12.2004EP published:
14.7.2010EP application number:
04814462.0
EPO information:
European Patent Register
Max expiry date:
15.12.2024
Title:
USE OF TREPROSTINIL TO TREAT ISCHEMIC LESIONS
Timeline
Today
16.12.2004EP application
14.7.2010EP Publication
Owner
Name:
United Therapeutics CorporationAddress:
1040 Spring Street Silver Spring, 20910, Maryland, US
Inventor
Name:
WADE, Michael,c/o United Therapeutics Corp.Address:
Research Triangle Park, NC, US
Name:
JEFFS, Roger A.,c/o United Therapeutics Corp.Address:
Research Triangle Park, NC, US
Name:
ROSCIGNO, Robert,c/o United Therapeutics Corp.Address:
Research Triangle Park, NC, US
Name:
STROOTMAN, Deborah,c/o United TherapeuticsAddress:
Tucson, AZ, US
Name:
BRONSTEIN, KathrynAddress:
Jupiter, FL, US
Priority
Number:
529622 PDate:
16.12.2003Country:
US
Classification
Categories:
A61K 31/191, A61K 31/201, A61P 9/10